NCT07199608

Brief Summary

Acne vulgaris is an inflammatory disease of pilosebaceous unit ,leading to different types of scars including atrophic, hypertrophic and keloidal. Atrophic scars are the most common type ,affecting about 75-90% of acne scar cases and can be ice pick, rolling or boxcar in morphology . Theses scars may cause significant impact such as depression, anxiety , and reduced quality of life. multiple treatment modalities exist, including lasers ,chemical peels, dermabrasion, microneedling, subcision and platelet rich plasma. Subcision is a well established technique that improves rolling and boxcar scars by releasing fibrotic strands. Fractional co2 laser induces dermal remodeling and collagen neogenesis, while PRP enhances wound healing and collagen induction through growth factors. Combinig subcision with either co2 laser or PRP may enhance treatment efficacy compared to subcision alone. rational : Subcision alone may provide limited improvement in some patients. Fractional CO₂ laser and PRP are promising adjunctive modalities that could enhance collagen remodeling and improve cosmetic outcomes. Evaluating their combined effect versus subcision alone will help determine the most effective and safe approach for managing atrophic post-acne scars. aim of work:To compare the efficacy and safety of combined subcision with either fractional CO₂ laser or platelet-rich plasma versus subcision alone in the treatment of facial atrophic post-acne scars.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Nov 2025Jan 2027

First Submitted

Initial submission to the registry

September 22, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 30, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 22, 2025

Last Update Submit

September 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Goodman and Baron quantitative acne scar score (Baseline vs 1 month post last session).

    If the scale was lowered by: (Quantitative) 0-5 points, the reduction will be considered minimal 5-10 points, it will be considered moderate reduction 10-15 points, it will be considered good reduction \>15 points, it will be considered very good reduction

    3 sessions per patient at 1-month intervals Follow-up: 1 month after last session

Secondary Outcomes (1)

  • Quartile grading scale improvement - Dermoscopic evaluation (erythema, pigmentation, photodamage, follicle density)

    3 sessions per patient at 1-month intervals Follow-up: 1 month after last session

Study Arms (3)

subcision alone

ACTIVE COMPARATOR
Procedure: subcision

subcision+fractional co2 laser

EXPERIMENTAL
Procedure: subcision+fractional co2 laser

subcision+platelet rich plasma

EXPERIMENTAL
Biological: subcision+PRP

Interventions

subcisionPROCEDURE

patients will undergo subcision procedure alone using 18 gauge blunt cannula to release fibrous bands under atrophic acne scars.this group will serve as control comparator

subcision alone

patients will undergo subcision procedure followed by fractional co2 laser applied to right side of face, the left side will receive subcision alone

subcision+fractional co2 laser
subcision+PRPBIOLOGICAL

patients will undergo subcision procedure followed by intradermal injection of autologous PRP prepared from patients blood on right side.left side will receive subcision alone

subcision+platelet rich plasma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Adult patients of both sexes with mild to severe atrophic post-acne scars.

You may not qualify if:

  • \- Age \< 18 years
  • Pregnant or lactating women
  • Active inflammatory acne or infection in treatment area
  • Premalignant or malignant lesions
  • Photosensitive dermatoses
  • Coagulation defects or blood disease
  • History of keloid scars
  • Systemic retinoid use in previous 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospitals, Dermatology Department

Asyut, Asyut Governorate, Egypt

Location

Related Publications (2)

  • Tran BQ, Tran TNA, Doan EVL, Nguyen TTP, Nguyen HT. Simultaneous versus sequential fractional CO2 laser and subcision combination for management of post-acne atrophic scars: A split-face comparative study. J Cosmet Dermatol. 2024 Oct;23(10):3210-3221. doi: 10.1111/jocd.16395. Epub 2024 May 21.

    PMID: 38770894BACKGROUND
  • Abdelwahab AA, Omar GAB, Hamdino M. A combined subcision approach with either fractional CO2 laser (10,600 nm) or cross-linked hyaluronic acid versus subcision alone in atrophic post-acne scar treatment. Lasers Med Sci. 2022 Dec 24;38(1):20. doi: 10.1007/s10103-022-03677-y.

    PMID: 36564573BACKGROUND

Related Links

Study Officials

  • Azza Mahfouz Abdel Meguid

    Assiut University

    STUDY CHAIR
  • Reham Maher Abd El Gaber

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Yasmeen Gamal Abdel Halim

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

September 22, 2025

First Posted

September 30, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

October 3, 2025

Record last verified: 2025-09

Locations